National Health Research Institutes, Taiwan
Clinical trials sponsored by National Health Research Institutes, Taiwan, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Light therapy during sleep may offer a Drug-Free path to better rest Results expected May 2027 (estimated)
- New drug cocktail aims to stall Hard-to-Treat gut tumors Results expected Aug 2027 (estimated)
- New study tests exercise as a Drug-Free way to boost leg blood flow in seniors Results expected Sep 2027 (estimated)
-
Triple drug combo targets Hard-to-Treat brain lymphoma
Disease control CompletedResearchers are testing a combination of rituximab, acalabrutinib, and durvalumab in adults with primary central nervous system lymphoma, a rare cancer that starts in the brain or spinal cord. The trial enrolls people whose disease has returned or worsened after earlier treatment…
Phase 1 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New chemo cocktail shows promise against tough bile duct cancer
Disease control CompletedThis study tested two different chemotherapy drug combinations in 92 people with advanced bile duct or gallbladder cancer that could not be removed by surgery. The goal was to see which combination better kept the cancer from growing for at least 6 months. Participants received e…
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New chemo cocktail shows promise against tough pancreatic cancer
Disease control CompletedThis phase II trial tested two chemotherapy combinations as first-line treatment for people with advanced or metastatic pancreatic cancer. One group received a newer regimen called SLOG, while the other got a standard combo called mFOLFIRINOX. The study aimed to see which worked …
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Digital mindfulness shows promise for caregiver burnout in dementia
Symptom relief CompletedThis study tested a 5-week online mindfulness program (AIZEN) for professional and family caregivers of people with dementia. Sixty caregivers in Taiwan attended weekly live classes and did daily 10-minute guided practices. Researchers measured burnout and caregiver burden before…
Sponsor: National Health Research Institutes, Taiwan • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Nationwide registry maps the course of a rare stomach tumor
Knowledge-focused CompletedResearchers in Taiwan are building a nationwide registry of people diagnosed with gastrointestinal stromal tumors, a rare cancer of the digestive tract. The study collects details on how the tumors are found, their stage, the treatments patients receive, and how they fare over ti…
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC